Xoma reported $-6427000 in EBIT for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US $ -41371000 16.23M
Agios Pharmaceuticals AGIO:US $ -91217000 1.22M
Ardelyx ARDX:US $ -32005000 4.36M
Biomarin Pharmaceutical BMRN:US $ 27.42M 59.74M
Bluebird Bio BLUE:US $ -230839000 25.98M
Celldex Therapeutics CLDX:US $ -16639000 6.36M
Chimerix CMRX:US -14563000 2.81M
Curis CRIS:US $ -8800000 2.52M
Eli Lilly And LLY:US $ 1666.2M 662.1M
Emergent Biosolutions EBS:US $ 95.4M 166.2M
Intercept Pharmaceuticals ICPT:US $ -29190000 10.8M
Life Technologies LIFE:US $ -7202000 2.26M
Macrogenics MGNX:US $ -51293000 49.12M
Novartis NOVN:VX 2.99B 332M
Novartis NVS:US 2.99B 332M
Pfizer PFE:US $ 5757M 4605M
Prothena PRTA:US -32109000 1.8M
Regeneron Pharmaceuticals REGN:US $ 1112.7M 54.3M
Teva Pharmaceutical Industries TEVA:US 794M 12M
Xoma XOMA:US $ -6427000 30.3M
YTE INCY:US $ 114.81M 65.45M